Navigation Links
BG Medical Technologies CEO to speak Friday at National Marijuana Business Conference
Date:11/7/2012

LOS ANGELES, Nov. 7, 2012 /PRNewswire/ -- BG Medical Technologies, Inc. (OTC: RIGH) CEO Angel Stanz is scheduled to speak on Friday, joining industry leaders at the aptly-timed National Marijuana Business Conference in Denver, Colorado. He appears alongside top industry professionals in technology, business operations, finance, law, and policy reform in discussing trends and forecasts for the medical cannabis industry. Mr. Stanz will focus specifically on Internet-related technologies and the profitable role they are expected to fill as the cannabis industry continues to expand.

"It is an absolute pleasure to be publicly speaking this week from the first state to fully repeal cannabis prohibition. Yesterday's election represents a historic moment that has further opened new frontiers in medical research, Internet applications, and data processing," stated CEO Angel Stanz. "The level of gravitas this moment represents for cannabis industry leaders is immeasurable. It strongly shines the spotlight on the benefits of regulated profit-earning models, stimulating local economies, and state revenues through taxation."

BG Medical Technologies reaffirms its 2013 plans to expand operations into Colorado and Washington State territories. BG Medical recognizes these locations as high-growth regions that will continue to foster development and influence across the national landscape.

About BG Medical Technologies

BG Medical Technologies develops technology and research software for the health industry with a focus on patient solutions for natural and herbal treatments, including medical cannabis. The Company collects data through a network of proprietary software, utilized by patients, retail operators, and medical professionals. The Company's current flagship product, BudGenius.com, is a social web platform designed to assist cannabis patients in selecting regionally available medicine that is paired to their needs. The Company operates an analyt
'/>"/>

SOURCE BG Medical Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Rochester Medical Corporation Announces Decision To Exit The Foley Catheter Business
2. Aethlon Medical Receives Intent to Issue Notice on European Patent to Remove Hepatitis C Virus (HCV), Human Immunodeficiency Virus (HIV), and Other Viral Pathogens From Blood
3. MetroStar Home Health Medical Equipment Steps Up Its Recovery Efforts to Aid Victims of Hurricane Sandy
4. Free LUNCH & LEARN featuring RTLS success at Methodist Medical Center of Illinois
5. Concord Medical to Report Third Quarter 2012 Financial Results on November 21, 2012
6. United Seating & Mobility Negotiates Purchase of Care Medical Equipments Rehab Division
7. Mindray Medical Announces Top Management Change
8. Second Webinar in MedTech Trends Webcast Series on November 28, 2012; Navigating & Understanding the Sealing and Handling of Medical Microporous Materials
9. Dynamic Healthcare Services Acquires Evanko Respiratory Inc., a Provider of Medical Equipment and Respiratory Therapy Products and Services in Hazleton, PA
10. Varian Medical Systems Management to Present at Jefferies 2012 Global Healthcare Conference
11. Varian Medical Systems Management to Present at Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014  Medela announced today ... Biomedical Company (ABC), assigning Medela as the exclusive distributor ... known as the Medela Enteral Feeding Pump. Through this ... help NICU parents and healthcare professionals by offering a ... Medela Enteral Feeding Pump is integral to the delivery ...
(Date:9/23/2014)... Sept. 23, 2014 A case report and ... SynCardia temporary Total Artificial Heart into a patient with ... were reversed, along with other abnormalities. ... the SynCardia Total Artificial Heart to treat a patient ... and video in the Journal of Visualized Experiments show ...
(Date:9/23/2014)... September 23, 2014 BerGenBio ... company, today announces it has been granted a ... Award from the UK,s Wellcome Trust to develop ... novel cancer target. The Wellcome Trust ... fund especially promising, innovative new therapeutic concepts through ...
Breaking Medicine Technology:Medela Enters Exclusive Enteral Feeding Pump Agreement with Atlanta Biomedical Company 21st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 21st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 31st Use of the SynCardia Total Artificial Heart in a 17-Year-Old Congenital Heart Disease Patient at Pediatric Hospital 4BerGenBio Granted a Prestigious Wellcome Trust Seeding Drug Discovery Award 2BerGenBio Granted a Prestigious Wellcome Trust Seeding Drug Discovery Award 3
... SYDNEY, Sept. 15 HeartWare International, Inc. (Nasdaq: ... less invasive, miniaturized circulatory support technologies that are revolutionizing ... CEO Doug Godshall is scheduled to make an investor ... on Tuesday, September 21, at 12:30 pm EDT.  The ...
... Md., Sept. 15 The U.S. Food and Drug ... recommendations for Valcyte (valganciclovir) oral tablets and solution used ... transplant. The update is intended to prevent drug overdosing ... area, and very low serum creatinine. The revised dosing ...
Cached Medicine Technology:HeartWare to Present at the UBS 2010 Global Life Sciences Conference 2FDA Issues New Dosing Guide for Children Using Valcyte 2
(Date:9/23/2014)... If you or a loved one ... treatment may be a challenge. Fortunately, an inventor from ... is designed to improve the experience. , He developed ... having to remove, tear or reposition their clothing. Furthermore, ... their dignity. At the same time, it safeguards their ...
(Date:9/23/2014)... been shown to be a driving force behind ... develops due to chronic inflammation caused by conditions ... relatively few effective treatment options. Now, scientists at ... for the first time in preclinical studies that ... astrocyte elevated gene-1 (AEG-1) halts the development and ...
(Date:9/23/2014)... Becker's Hospital Review has published ... Hospitals and Health Systems With Great Orthopedic Programs." ... the list have orthopedic surgery departments, programs or ... reputable sources. Exceptional orthopedic departments include physicians who ... and treat professional athletes. , This is the ...
(Date:9/23/2014)... the curve of oxygen desaturation" (AUC Desat ) may ... levels during procedures using sedation, according to a study ... AUC Desat provides information not only whether blood ... duration, and rate of episodes of oxygen desaturation. ... of Cincinnati and colleagues reports on the development of ...
(Date:9/23/2014)... Contrary to what is often assumed about single parents, ... from The Kinsey Institute has found that single parents ... active as often as singles without children -- and ... The study, "Dating and Sexual Behavior Among Single Parents ... online in the Journal of Sex Research ...
Breaking Medicine News(10 mins):Health News:Apparel for Dialysis Patients Invented by InventHelp Client (CBA-2492) 2Health News:Study uncovers genetic driver of inflammation, uses it to prevent and treat liver cancer 2Health News:125 Hospitals With Great Orthopedic Programs 2Health News:125 Hospitals With Great Orthopedic Programs 3Health News:125 Hospitals With Great Orthopedic Programs 4Health News:125 Hospitals With Great Orthopedic Programs 5Health News:New measure provides more data on oxygen levels during sedation 2Health News:Kinsey study of single parents' dating, sexual activity contradicts assumptions 2
... WASHINGTON, Aug. 9 SEIU ... wherever they occur. We are ... been raised concerning SEIU Local ... Union, and will take any ...
... fade after first injection, so second shot now recommended , , ... chickenpox was introduced in the United States in 1995, medical ... single injection about the time of a child,s first birthday ... so. They,ve found that the protection from a single immunization ...
... Responding to increased concerns about the health hazards ... employed the use of the Mini C-Arm throughout ... week are bringing this advanced technology to their ... patient care, Nighttime Care Centers have introduced the ...
... of Miley Cyrus and,the Jonas Brothers will have more ... artists take the stage with other performers at Disney,s,Concert ... programs at City of Hope. It will be held ... Tickets for the concert will,be available Saturday, August 16 ...
... PD-Rx Pharmaceuticals,Inc., a publicly held corporation, (Pink Sheets: ... of all of its outstanding Preferred "A",stock., ... Cumulative,Convertible Stock representing One Hundred and Sixty Five ... Inc. The,stock call represents PD-Rx,s position to improve ...
... Aug. 8 /PRNewswire/ - IntelliPharmaCeutics is pleased to,provide ... press release to,the Company, include IntelliPharmaCeutics Ltd. and ... been very active with drug development work at ... Toronto, Canada. We,presently have 34 staff employed full-time ...
Cached Medicine News:Health News:Chickenpox Protection: Get That Booster 2Health News:Chickenpox Protection: Get That Booster 3Health News:Nighttime Care Centers Introduce Mini C-Arm Mobile X-Ray Technology to Anne Arundel County 2Health News:Nighttime Care Centers Introduce Mini C-Arm Mobile X-Ray Technology to Anne Arundel County 3Health News:The Walt Disney Company Is Presenting Miley Cyrus, Jonas Brothers and Demi Lovato in a Special Concert to Benefit City of Hope on September 14 2Health News:The Walt Disney Company Is Presenting Miley Cyrus, Jonas Brothers and Demi Lovato in a Special Concert to Benefit City of Hope on September 14 3Health News:PD-Rx Completes Call for Preferred A Stock 2Health News:IntelliPharmaCeutics Provides Update on Activities 2Health News:IntelliPharmaCeutics Provides Update on Activities 3Health News:IntelliPharmaCeutics Provides Update on Activities 4
... for the Humphrey Field Analyzer, SITA ... shows less inter-test variability than Full ... of reproducibility as Full Threshold SWAP. ... with the earlier glaucoma damage detected ...
... you can trust its capabilities will ... cataract, and glaucoma therapy in one ... is the optimal system for photocoagulation, ... iridotomy. The push of a button ...
... The VISUCAM non-mydriatic ... quality and simplicity of ... big enough to set ... photography, it features a ...
... YAG III is the new disruption ... in particular for applications in posterior ... the YAG laser is also used ... IOL polishing. It's another milestone in ...
Medicine Products: